National Health Research Institutes, Taiwan

This study tests whether adding two immunotherapy drugs (nivolumab and relatlimab) to standard chemotherapy can shrink tumors better than one immunotherapy drug plus chemo in people with advanced bile duct cancer. About 76 adults who have not had prior treatment for their advance…

This study tests the drug cabozantinib in 60 adults with advanced liver cancer that got worse after initial immunotherapy. The goal is to see if cabozantinib can stop or slow tumor growth for at least 6 months. Researchers will also look for blood or tissue markers that predict w…

This study tests whether an internet-based therapy program (ICBT) can help adults with generalized anxiety disorder or major depressive disorder. About 160 participants will either get their usual care or usual care plus an 8-week online course with 12 modules. The goal is to see…

This study tests whether a smart wearable wristband can help older adults with disabilities become more active and improve the quality of care they receive at home. About 1,080 participants, including seniors, their family caregivers, and care providers, will use the wristband fo…